Teladoc Appoints Former CEO of Allina Health Ken Paulus to Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Teladoc (TDOC) PT Raised to $27 at Oppenheimer Following 4Q Report
March 2, 2017 9:22 AM ESTOppenheimer raised its price target on Teladoc (NYSE: TDOC) to $27.00 (from $23.00) while maintaining a Outperform rating. TDOC reported Q4 revenues of $37.4M vs. consensus' $36.8M. Adjusted EPS loss in Q4 was ($0.31) vs. consensus' ($0.34) estimate.
Analyst Mohan Naidu commented, "TDOC's Q416 results and... More
